FDA SCRUTINIZES OFF-LABEL PROMOTIONS

被引:7
作者
RANDALL, T
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1991年 / 266卷 / 01期
关键词
D O I
10.1001/jama.266.1.11
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:11 / 11
页数:1
相关论文
共 50 条
[31]   Off-Label Pharmacovigilance [J].
Edwards, I. Ralph .
DRUG SAFETY, 2011, 34 (10) :795-797
[32]   Off-Label Pharmacovigilance [J].
I. Ralph Edwards .
Drug Safety, 2011, 34 :795-797
[33]   The "Off-label" TAVI [J].
Kornowski, Ran .
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (08) :443-444
[34]   Marketing off-label uses to physicians: FDA's draft (mis)guidance [J].
Gass, Andy ;
Wilson, Jennifer .
AMERICAN JOURNAL OF BIOETHICS, 2008, 8 (03) :1-3
[35]   FDA policies on DTC advertising, off-label information dissemination under attack [J].
Wechsler, J .
FORMULARY, 1998, 33 (10) :1033-1034
[36]   The first amendment and FDA restrictions on off-label uses: The call for a new approach [J].
Leghorn, Joseph ;
Brophy, Elizabeth ;
Rother, Peter V. .
FOOD AND DRUG LAW JOURNAL, 2008, 63 (02) :391-406
[37]   Off-label perils [J].
不详 .
COMPENDIUM ON CONTINUING EDUCATION FOR THE PRACTICING VETERINARIAN, 2004, 26 (11) :834-834
[38]   Off-label therapy [J].
Myers, Gary .
NEW SCIENTIST, 2014, 223 (2983) :29-29
[39]   "Off-label" deworming [J].
Boissevain, Iaira .
TIJDSCHRIFT VOOR DIERGENEESKUNDE, 2009, 134 (21) :897-897
[40]   Going off-label [J].
Lucas, Catherine .
LANCET CHILD & ADOLESCENT HEALTH, 2018, 2 (08) :556-556